drugset / Trial / NCT02725736

Tocolytic Therapy for Preterm Labor in Multiple Gestation

NCT02725736

Phase 3 Unknown 140 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the tocolytic efficacy oxytocin receptor antagonist (Atosiban) with that of calcium channel blockers (Nifedipine) among women with multiple gestation who present with threatened preterm labor.

Timeline

Start
2016-03
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atosiban Other / unclassified 100 ug Intravenous
Subject Nifedipine Other / unclassified 20 mg Oral
Subject Nifedipine Other / unclassified 40 mg Oral

Indications

No indication recorded.